Log in
NASDAQ:RLAY

Relay Therapeutics News Headlines

$39.88
-0.39 (-0.97 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$38.90
Now: $39.88▼
$41.40
50-Day Range
$35.15
MA: $39.93▼
$45.15
52-Week Range
$32.56
Now: $39.88▼
$49.89
Volume123,206 shs
Average Volume261,435 shs
Market Capitalization$3.59 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Relay Therapeutics (NASDAQ RLAY) News Headlines Today

Source:
DateHeadline
Relay Therapeutics (NASDAQ:RLAY) Trading 5.2% Higher Relay Therapeutics (NASDAQ:RLAY) Trading 5.2% Higher
americanbankingnews.com - October 22 at 9:01 PM
Rosetta Stone Inc. (RST)Rosetta Stone Inc. (RST)
finance.yahoo.com - October 19 at 11:03 PM
Relay Therapeutics (NASDAQ:RLAY) Expected to Announce Earnings of -$0.36 Per ShareRelay Therapeutics (NASDAQ:RLAY) Expected to Announce Earnings of -$0.36 Per Share
americanbankingnews.com - October 18 at 11:29 AM
Are Insiders Buying Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock?Are Insiders Buying Relay Therapeutics, Inc. (NASDAQ:RLAY) Stock?
finance.yahoo.com - October 17 at 12:06 AM
Relay Therapeutics (NASDAQ:RLAY) Shares Up 8.1%Relay Therapeutics (NASDAQ:RLAY) Shares Up 8.1%
americanbankingnews.com - October 16 at 7:01 PM
Relay Therapeutics (NASDAQ:RLAY) Trading Up 9.9%Relay Therapeutics (NASDAQ:RLAY) Trading Up 9.9%
americanbankingnews.com - October 5 at 7:26 PM
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2
bloomberg.com - September 30 at 7:10 PM
Relay Therapeutics (NASDAQ:RLAY) Trading Up 5.2%Relay Therapeutics (NASDAQ:RLAY) Trading Up 5.2%
americanbankingnews.com - September 29 at 7:31 PM
Oak Stone Limited Says Relay Therapeutics IPO Soars In Trading DebutOak Stone Limited Says Relay Therapeutics IPO Soars In Trading Debut
bloomberg.com - September 26 at 8:51 AM
Relay Therapeutics rallies 7% on EcoR1 pitchRelay Therapeutics rallies 7% on EcoR1 pitch
seekingalpha.com - September 23 at 1:46 PM
51 Stocks Moving In Mondays Mid-Day Session51 Stocks Moving In Monday's Mid-Day Session
benzinga.com - September 21 at 2:00 PM
Dosing underway in Relay Therapeutics first-in-human RLY-4008 trialDosing underway in Relay Therapeutics' first-in-human RLY-4008 trial
seekingalpha.com - September 4 at 7:34 AM
Relay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 InhibitorRelay Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Trial of RLY-4008, a Highly Selective FGFR2 Inhibitor
finance.yahoo.com - September 3 at 4:33 PM
Relay Therapeutics EPS misses by $5.03Relay Therapeutics EPS misses by $5.03
seekingalpha.com - August 27 at 8:31 AM
Relay Therapeutics Reports Second Quarter 2020 Financial ResultsRelay Therapeutics Reports Second Quarter 2020 Financial Results
finance.yahoo.com - August 27 at 8:31 AM
SoftBank Returns to Profit After Record LossesSoftBank Returns to Profit After Record Losses
finance.yahoo.com - August 11 at 3:07 AM
This page was last updated on 10/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.